10:03 AM EST - Opsens Inc. : Today reported its results for the third quarter of 2019. Consolidated revenues were $7.9 million for the third quarter of 2019 compared with $6.4 M for the third quarter of 2018, an increase of $1.5 M or 23%. Fractional Flow Reserve ("FFR") sales of $5.2 M for the third quarter of 2019 compared with $3.5 M for the same period last year, an increase of 49%. There was also a 44% increase in FFR revenues in the United States compared with the same quarter in 2018. The company also forged a landmark supply agreement signed with Abiomed, Inc. Opsens Inc.
shares T.OPS are trading up $0.07 at $0.98.
